Fitzgerald Meghan (CIK 1349297) reported 16 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-18). Recent activity: Buy ROIV (5,054 shares), Sell ROIV (4,712 shares), Sell ROIV (400 shares), Sell ROIV (1,743 shares), Buy ROIV (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 5,054 | $0 |
| 2026-09-17 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 4,712 | $186,972 |
| 2026-09-17 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 400 | $16,180 |
| 2026-09-14 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 1,743 | $71,358 |
| 2026-09-10 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 20,000 | $176,000 |
| 2026-09-10 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 20,000 | $798,000 |
| 2026-07-02 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 10,000 | $88,000 |
| 2026-07-02 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 10,000 | $349,000 |
| 2026-05-26 | TENET HEALTHCARE CORP (THC) | Director | Buy | 1,333 | $0 |
| 2026-05-26 | TENET HEALTHCARE CORP (THC) | Director | Sell | 493 | $85,674 |
| 2026-03-30 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 70,000 | $616,000 |
| 2026-03-30 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 70,000 | $1.9M |
| 2025-09-12 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 14,524 | $0 |
| 2025-09-12 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 937 | $12,902 |
| 2025-05-27 | TENET HEALTHCARE CORP (THC) | Director | Buy | 1,551 | $0 |
| 2025-05-27 | TENET HEALTHCARE CORP (THC) | Director | Sell | 573 | $92,442 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18